Loading...
An RNA-based digital circulating tumor cell signature is predictive of drug response and early dissemination in prostate cancer
Blood-based biomarkers are critical in metastatic prostate cancer, where characteristic bone metastases are not readily sampled, and they may enable risk stratification in localized disease. We established a sensitive and high-throughput strategy for analyzing prostate circulating tumor cells (CTCs)...
Na minha lista:
| Udgivet i: | Cancer Discov |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342192/ https://ncbi.nlm.nih.gov/pubmed/29301747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-1406 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|